1.Hemodynamic Changes Following Surfactant Therapy in Infants With Respiratory Distress Syndrome.
Senji SHIMADA ; Takeo KASAI ; Atsuki HOSHI ; Atsushi MURATA ; Shoichi CHIDA ; Tetsuro FUJIWARA
Journal of the Korean Society of Neonatology 1997;4(1):111-118
No abstract available.
Hemodynamics*
;
Humans
;
Infant*
2.Diagnostic Approach and Surfactant Treatment in RDS.
Shoichi CHIDA ; Tetsuro FUJIWARA ; Senji SHIMADA ; Takeo KASAI ; Atsushi MURATA ; Atsuki HOSHI
Journal of the Korean Society of Neonatology 1997;4(1):106-110
No abstract available.
3.Ulcerative Colitis and Immunoglobulin G4.
Go KUWATA ; Terumi KAMISAWA ; Koichi KOIZUMI ; Taku TABATA ; Seiichi HARA ; Sawako KURUMA ; Takashi FUJIWARA ; Kazuro CHIBA ; Hideto EGASHIRA ; Junko FUJIWARA ; Takeo ARAKAWA ; Kumiko MOMMA ; Shinichiro HORIGUCHI
Gut and Liver 2014;8(1):29-34
BACKGROUND/AIMS: Ulcerative colitis (UC) is sometimes associated with autoimmune pancreatitis (AIP). Infiltration of immunoglobulin G4 (IgG4)-positive plasma cells is sometimes detected in the colonic mucosa of AIP or UC patients. This study aimed to clarify the relation between UC and IgG4. METHODS: Associations with UC were reviewed in 85 AIP patients. IgG4 immunostaining was performed on biopsy specimens from the colonic mucosa of 14 AIP and 32 UC patients. RESULTS: UC was confirmed in two cases (type 1 AIP, n=1; suspected type 2 AIP, n=1). Abundant infiltration of IgG4-positive plasma cells in the colonic mucosa was detected in the case of suspected type 2 AIP with UC and two cases of type 1 AIP without colitis. Abundant infiltration of IgG4-positive plasma cells was detected in 10 UC cases (IgG4-present, 31%). Although 72% of IgG4-absent UC patients showed mild disease activity, 70% of IgG4-present patients showed moderate to severe disease activity (p<0.05). CONCLUSIONS: UC is sometimes associated with AIP, but it seems that UC is not a manifestation of IgG4-related disease. Infiltration of IgG4-positive plasma cells is sometimes detectable in the colonic mucosa of UC patients and is associated with disease activity.
Adult
;
Aged
;
Colitis, Ulcerative/*blood/complications
;
Colon/*chemistry
;
Female
;
Humans
;
Immunoglobulin G/*analysis
;
Intestinal Mucosa/*chemistry
;
Male
;
Middle Aged
;
Pancreatitis/*blood/complications
;
Retrospective Studies
4.Clinical Characteristics of Patients with Autoimmune Pancreatitis with or without Mikulicz's Disease and Mikulicz's Disease Alone.
Sawako KURUMA ; Terumi KAMISAWA ; Taku TABATA ; Seiichi HARA ; Takashi FUJIWARA ; Go KUWATA ; Hideto EGARASHIRA ; Koichi KOIZUMI ; Keigo SETOGUCHI ; Junko FUJIWARA ; Takeo ARAKAWA ; Kumiko MOMMA ; Toshio MITSUHASHI ; Tsuneo SASAKI
Gut and Liver 2013;7(1):96-99
BACKGROUND/AIMS: The objective of this study was to compare the clinical characteristics of patients with autoimmune pancreatitis (AIP) with or without Mikulicz's disease (MD) and with MD alone. METHODS: We investigated the clinical findings in 15 AIP patients with MD (group A+M), 49 AIP only patients (group A), and 14 MD only patients (group M). RESULTS: The male-female ratio was significantly higher in group A+M (73%, p<0.05) and group A (78%, p<0.01) than group M (21%). Serum immunoglobulin G (IgG) levels were significantly higher in group A+M than in group A (p<0.01) and group M (p<0.05). Serum IgG4 levels were significantly higher in group A+M than in group A (p<0.01). Other organ involvement was observed in 73% (11/15) of patients in group A+M. The number of patients with diabetes mellitus was significantly higher in group A+M (66%, p<0.01) and group A (51%, p<0.05) than in group M (7%). All of the patients responded well to steroid therapy, but the relapse rate in group A+M (33%) was significantly higher than that in group A (3%, p<0.01). Salivary gland function was impaired in all groups compared with the control group, but the degree of dysfunction was less in group A compared with group A+M and group M. CONCLUSIONS: The relapse rate of AIP in MD patients was significantly higher than that of AIP in patients without MD.
Diabetes Mellitus
;
Humans
;
Immunoglobulin G
;
Mikulicz' Disease
;
Pancreatitis
;
Recurrence
;
Salivary Glands
5.Organ Correlation in IgG4-Related Diseases.
Satomi KOIZUMI ; Terumi KAMISAWA ; Sawako KURUMA ; Taku TABATA ; Kazuro CHIBA ; Susumu IWASAKI ; Go KUWATA ; Takashi FUJIWARA ; Junko FUJIWARA ; Takeo ARAKAWA ; Koichi KOIZUMI ; Kumiko MOMMA
Journal of Korean Medical Science 2015;30(6):743-748
IgG4-related disease (IgG4-RD) is a potentially multiorgan disorder. In this study, clinical and serological features from 132 IgG4-RD patients were compared about organ correlations. Underlying pathologies comprised autoimmune pancreatitis (AIP) in 85 cases, IgG4-related sclerosing cholangitis (IgG4-SC) in 12, IgG4-related sialadenitis (IgG4-SIA) in 56, IgG4-related dacryoadenitis (IgG4-DAC) in 38, IgG4-related lymphadenopathy (IgG4-LYM) in 20, IgG4-related retroperitoneal fibrosis (IgG4-RF) in 19, IgG4-related kidney disease (IgG4-KD) in 6, IgG4-related pseudotumor (IgG4-PT) in 3. Sixty-five patients (49%) had multiple IgG4-RD (two affected organs in 36 patients, three in 19, four in 8, five in 1, and six in 1). Serum IgG4 levels were significantly higher with multiple lesions than with a single lesion (P<0.001). The proportion of association with other IgG4-RD was 42% in AIP, the lowest of all IgG4-RDs. Serum IgG4 level was lower in AIP than in other IgG4-RDs. Frequently associated IgG4-RDs were SIA (25%) and DAC (12%) for AIP; AIP (75%) for IgG4-SC; DAC (57%), AIP (38%) and LYM (27%) for IgG4-SIA; AIP (26%) and LYM (26%) for IgG4-DAC; SIA (75%), DAC (50%) and AIP (45%) for IgG4-LYM; SIA (58%), AIP (42%) and LYM (32%) for IgG4-RF; AIP (100%) and SIA (67%) for IgG4-KID; and DAC (67%) and SIA (67%) for IgG4-PT. Most associated IgG4-RD lesions were diagnosed simultaneously, but IgG4-SIA and IgG4-DAC were sometimes identified before other lesions. About half of IgG4-RD patients had multiple IgG4-RD lesions, and some associations were seen between specific organs.
Adult
;
Aged
;
Autoimmune Diseases/*epidemiology/*immunology
;
Comorbidity
;
Female
;
Humans
;
Immunoglobulin G/*immunology
;
Japan/epidemiology
;
Male
;
Middle Aged
;
Multiple Organ Failure/*epidemiology/*immunology
;
Organ Specificity/immunology
;
Prevalence
;
Risk Factors
;
Statistics as Topic
6.Characteristic Findings of Endoscopic Retrograde Cholangiopancreatography in Autoimmune Pancreatitis.
Susumu IWASAKI ; Terumi KAMISAWA ; Satomi KOIZUMI ; Kazuro CHIBA ; Taku TABATA ; Sawako KURUMA ; Go KUWATA ; Takashi FUJIWARA ; Koichi KOIZUMI ; Takeo ARAKAWA ; Kumiko MOMMA ; Seiichi HARA ; Yoshinori IGARASHI
Gut and Liver 2015;9(1):113-117
BACKGROUND/AIMS: Diffuse or segmental irregular narrowing of the main pancreatic duct (MPD), as observed by endoscopic retrograde cholangiopancreatography (ERCP), is a characteristic feature of autoimmune pancreatitis (AIP). METHODS: ERCP findings were retrospectively examined in 40 patients with AIP in whom irregular narrowing of the MPD was detected near the orifice. The MPD opening sign was defined as the MPD within 1.5 cm from the orifice being maintained. The distal common bile duct (CBD) sign was defined as the distal CBD within 1.5 cm from the orifice being maintained. Endoscopic findings of a swollen major papilla and histological findings of specimens obtained from the major papilla were examined in 26 and 21 patients, respectively. RESULTS: The MPD opening sign was detected in 26 of the 40 patients (65%). The distal CBD sign was detected in 25 of the 32 patients (78%), which showed stenosis of the lower bile duct. The patients who showed the MPD opening sign frequently showed the distal CBD sign (p=0.018). Lymphoplasmacytic infiltration, but not dense fibrosis, was histologically detected in biopsy specimens obtained from the major papilla. CONCLUSIONS: On ERCP, the MPD and CBD adjacent to the major papilla are frequently maintained in patients with AIP involving the pancreatic head. These signs are useful for diagnosing AIP on ERCP.
Autoimmune Diseases/*diagnosis/pathology
;
*Cholangiopancreatography, Endoscopic Retrograde
;
Common Bile Duct/pathology
;
Female
;
Humans
;
Male
;
Middle Aged
;
Pancreas/pathology
;
Pancreatic Ducts/pathology
;
Pancreatitis/*diagnosis/pathology
;
Retrospective Studies
7.Short and Long-Term Outcomes of Diabetes Mellitus in Patients with Autoimmune Pancreatitis after Steroid Therapy.
Yuji MIYAMOTO ; Terumi KAMISAWA ; Taku TABATA ; Seiichi HARA ; Sawako KURUMA ; Kazuro CHIBA ; Yoshihiko INABA ; Go KUWATA ; Takashi FUJIWARA ; Hideto EGASHIRA ; Koichi KOIZUMI ; Ryoko SEKIYA ; Junko FUJIWARA ; Takeo ARAKAWA ; Kumiko MOMMA ; Toru ASANO
Gut and Liver 2012;6(4):501-504
BACKGROUND/AIMS: Autoimmune pancreatitis (AIP) is frequently associated with diabetes mellitus (DM). This study evaluated the effect of steroid therapy on the course of DM in AIP. METHODS: Glucose tolerance was examined in 69 patients with AIP. DM onset was classified as either a simultaneous onset with AIP or an exacerbation of pre-existing DM. Based on the changes in the HbA1c levels and insulin dose, the responses of DM to steroids were classified as improved, no change, or worsened. RESULTS: Thirty (46%) patients were diagnosed as having DM (simultaneous onset, n=17; pre-existing, n=13). Three months after starting the steroid treatment, the DM improved in 13 (54%) of 24 DM patients. The DM improved in 55%, had no change in 36%, and worsened in 9% of the 11 simultaneous onset DM patients, and it improved in 54%, had no change in 31%, and worsened in 15% of the 13 pre-existing DM patients. At approximately 3 years after starting the steroid treatment, the DM improved in 10 (63%) of 16 patients. The pancreatic exocrine function improved in parallel with the changes in the DM in seven patients. CONCLUSIONS: Because approximately 60% of DM associated with AIP is responsive to steroids in the short- and long-terms, marked DM associated with AIP appears to be an indication for steroid therapy.
Diabetes Mellitus
;
Glucose
;
Humans
;
Insulin
;
Pancreatitis
;
Steroids
8.Differentiating Immunoglobulin G4-Related Sclerosing Cholangitis from Hilar Cholangiocarcinoma.
Taku TABATA ; Terumi KAMISAWA ; Seiichi HARA ; Sawako KURUMA ; Kazuro CHIBA ; Go KUWATA ; Takashi FUJIWARA ; Hideto EGASHIRA ; Koichi KOIZUMI ; Junko FUJIWARA ; Takeo ARAKAWA ; Kumiko MOMMA ; Masanao KURATA ; Goro HONDA ; Koji TSURUTA ; Takao ITOI
Gut and Liver 2013;7(2):234-238
BACKGROUND/AIMS: Few studies have differentiated immunoglobulin G (IgG) 4-related sclerosing cholangitis (IgG4-SC) from hilar cholangiocarcinoma (CC). Thus, we sought to investigate useful features for differentiating IgG4-SC from hilar CC. METHODS: We retrospectively compared clinical, serological, imaging, and histological features of six patients with IgG4-SC and 42 patients with hilar CC. RESULTS: In patients with hilar CC, obstructive jaundice was more frequent (p<0.01), serum total bilirubin levels were significantly higher (p<0.05), serum CA19-9 levels were significantly higher (p<0.01), and serum duke pancreatic monoclonal antigen type 2 levels were frequently elevated (p<0.05). However, in patients with IgG4-SC, the serum IgG (p<0.05) and IgG4 (p<0.01) levels were significantly higher and frequently elevated. The pancreas was enlarged in all IgG4-SC patients but only in 17% of hilar CC patients (p<0.01). Salivary and/or lacrimal gland swelling was detected in only 50% of IgG4-SC patients (p<0.01). Endoscopic retrograde cholangiography revealed that the hilar or hepatic duct was completely obstructed in 83% of hilar CC patients (p<0.01). Lower bile duct stenosis, apart from hilar bile duct stenosis, was more frequent in IgG4-SC patients (p<0.01). Bile duct wall thickening in areas without stenosis was more frequent in IgG4-SC patients (p<0.01). CONCLUSIONS: An integrated diagnostic approach based on clinical, serological, imaging, and histological findings is necessary to differentiate IgG4-SC from hilar CC.
Bile Ducts
;
Bilirubin
;
Cholangiocarcinoma
;
Cholangiography
;
Cholangiopancreatography, Endoscopic Retrograde
;
Cholangitis, Sclerosing
;
Constriction, Pathologic
;
Hepatic Duct, Common
;
Humans
;
Immunoglobulin G
;
Immunoglobulins
;
Jaundice, Obstructive
;
Lacrimal Apparatus
;
Pancreas
;
Retrospective Studies
9.Feature of “qi, Blood, Fluid” Factors in Patients with Sjögrenʼs Syndrome : In Comparison with Patients of Rheumatoid Arthritis in Remission
Takeo ABE ; Masao TAMURA ; Koji OH ; Hiroyuki FUJIWARA
Kampo Medicine 2021;72(3):227-234
To determine the body constituents patterns comprised of “qi, blood, fluid” factors associated with oral health-related QOL (OHRQOL) of patients with Sjögren's syndrome (SS), 41 SS patients and 32 RA patients in remission were enrolled. The body constituents patterns were measured by using Terasawa's “qi, blood, fluid” score, and the simple version of yin deficiency questionnaire (yin-deficiency score). OHRQOL were evaluated using the oral health impact profile (OHIP-14). In the first study, the body constituents pattern scores were compared between SS group and RA (in remission) group, using the univariate and multivariate analysis. In the second study, the association between OHIP14 and the body constituents pattern scores was analyzed. In the first study, all the scores were significantly higher in SS group, and the multivariable logistic regression identified yin deficiency (p = 0.02) and blood stasis (p = 0.01) as the significantly associated factors with SS group. In the second study, all the scores, except for the blood stasis pattern, showed positive correlation with OHIP-14. The multiple regression analysis identified qi stagnation (p = 0.003) as the significantly associated factors with OHIP-14. This study revealed that yin deficiency and blood stasis are the significant body constituent patterns in SS patients. In the low OHRQOL cases, qi stagnation should be taken into consideration.
10.Phenotypic characteristics of pediatric inflammatory bowel disease in Japan: results from a multicenter registry
Katsuhiro ARAI ; Reiko KUNISAKI ; Fumihiko KAKUTA ; Shin-ichiro HAGIWARA ; Takatsugu MURAKOSHI ; Tadahiro YANAGI ; Toshiaki SHIMIZU ; Sawako KATO ; Takashi ISHIGE ; Tomoki AOMATSU ; Mikihiro INOUE ; Takeshi SAITO ; Itaru IWAMA ; Hisashi KAWASHIMA ; Hideki KUMAGAI ; Hitoshi TAJIRI ; Naomi IWATA ; Takahiro MOCHIZUKI ; Atsuko NOGUCHI ; Toshihiko KASHIWABARA ; Hirotaka SHIMIZU ; Yasuo SUZUKI ; Yuri HIRANO ; Takeo FUJIWARA
Intestinal Research 2020;18(4):412-420
Background/Aims:
There are few published registry studies from Asia on pediatric inflammatory bowel disease (IBD). Registry network data enable comparisons among ethnic groups. This study examined the characteristics of IBD in Japanese children and compared them with those in European children.
Methods:
This was a cross-sectional multicenter registry study of newly diagnosed Japanese pediatric IBD patients. The Paris classification was used to categorize IBD features, and results were compared with published EUROKIDS data.
Results:
A total of 265 pediatric IBD patients were initially registered, with 22 later excluded for having incomplete demographic data. For the analysis, 91 Crohn’s disease (CD), 146 ulcerative colitis (UC), and 6 IBD-unclassified cases were eligible. For age at diagnosis, 20.9% of CD, 21.9% of UC, and 83.3% of IBD-unclassified cases were diagnosed before age 10 years. For CD location, 18.7%, 13.2%, 64.8%, 47.3%, and 20.9% were classified as involving L1 (ileocecum), L2 (colon), L3 (ileocolon), L4a (esophagus/stomach/duodenum), and L4b (jejunum/proximal ileum), respectively. For UC extent, 76% were classified as E4 (pancolitis). For CD behavior, B1 (non-stricturingon-penetrating), B2 (stricturing), B3 (penetrating), and B2B3 were seen in 83.5%, 11.0%, 3.3%, and 2.2%, respectively. A comparison between Japanese and European children showed less L2 involvement (13.2% vs. 27.3%, P< 0.01) but more L4a (47.3% vs. 29.6%, P< 0.01) and L3 (64.8% vs. 52.7%, P< 0.05) involvement in Japanese CD children. Pediatric perianal CD was more prevalent in Japanese children (34.1% vs. 9.7%, P< 0.01).
Conclusions
Upper gastrointestinal and perianal CD lesions are more common in Japanese children than in European children.